drugset / Trial / NCT03475615
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to compare the efficacy of intraperitoneal paclitaxel in combination with SOX, with SOX alone in the first-line treatment of gastric cancer with malignant ascites
Timeline
- Start
- 2018-03-16
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 40 mg/m2 | Other |
| Background | Oxaliplatin | Small molecule | 130 mg/m2 | — |
| Background | S-1 | Small molecule | 40 mg/m2 | Oral |